Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.35934 | 53 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.33892 | 54 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.34722 | 54 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.19317 | 52 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.2853 | 54 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.58717 | 58 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.61154 | 59 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.31852 | 54 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.30242 | 54 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.32838 | 54 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.3264 | 54 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.31119 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.35467 | 54 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.36571 | 55 |